Patent ID: 9072876
Filing Date: 2015-07-07
Classification: A61K,A61M,B05B

Abstract:
1. A method of treating a patient having a dermal and/or mucosal-associated condition with a topical semi-solid imiquimod pharmaceutical formulation, said method comprising: actuating a dispensing device, the dispensing device comprising a dispensing package that includes a hollow main body portion and a manually-operated airless pumping device mounted on the main body portion, the main body portion defining a fluid storage chamber and the airless pumping device defining a dispensing duct which terminates in a self-closing discharge orifice, the fluid storage chamber being pre-filled with the imiquimod pharmaceutical formulation, wherein manual operation of the airless pumping device causes a portion of the imiquimod cream to be withdrawn from within the fluid storage chamber into the dispensing duct thereby opening the self-closing discharge orifice dispensing the imiquimod formulation from the dispensing package through the self-closing discharge orifice so as to dispense therefrom an effective unit-dose amount of the topical semi-solid imiquimod pharmaceutical formulation for treating the dermal and/or mucosal-associated condition; and applying the effective unit-dose amount to a treatment area diagnosed with the dermal and/or mucosal-associated condition in accordance with an effective treatment regimen to treat the dermal and/or mucosal-associated condition.